Nearly HALF of Patients with Serious COVID Vaccine Injuries Die Within 6 Weeks, Study Finds
By The Vigilant Fox
The media won’t say a word about this.
Guest post by Nicolas Hulscher, MPH
Korean government study finds 44.7% case-fatality rate within 42 days for severe serious adverse events — highest in mix-and-match recipients and nursing home patients.
A new Korean government-backed study titled, Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study, was just published in the journal PLoS One:
Here’s what they found:
Overall Mortality Among Patients with Severe Serious Adverse Events (SAEs)
Breakdown by vaccine strategy:
- Heterologous “Mix n’ Match” (viral vector + mRNA): 36 deaths / 63 cases = 57.1% mortality
- Homologous viral vector: 34 deaths / 75 cases = 45.3%
- Homologous mRNA (Pfizer/Moderna): 90 deaths / 220 cases = 40.9%
Mixing Vaccine Types Significantly Increased Mortality Risk
Vaccination Site Strongly Associated with Death Risk
- Medical institutions (e.g., clinics/hospitals):
- aHR: 2.776 — Nearly 3x higher mortality
- Nursing homes / long-term care:
- aHR: 4.374 — Over 4x higher mortality
- Community health centers:
- aHR: 3.945 — Nearly 4x higher mortality
Fraiman et al reanalyzed the Pfizer and Moderna trials, and found a serious adverse event rate of 1 in 800 COVID-19 vaccine recipients. According to this Korean government-backed study, around 45% of those individuals may die within 42 days.
This supports the conservative U.S. COVID-19 vaccine death estimate of 470,000–600,000:
A few days ago, Joe Rogan mentioned my X post showing this graphic, and that the COVID-19 vaccines have resulted in more American casualties than WWI, WWII, and Vietnam combined:
